177 related articles for article (PubMed ID: 28032992)
1. Cationic Amphiphilic Tris-Cyclometalated Iridium(III) Complexes Induce Cancer Cell Death via Interaction with Ca
Hisamatsu Y; Suzuki N; Masum AA; Shibuya A; Abe R; Sato A; Tanuma SI; Aoki S
Bioconjug Chem; 2017 Feb; 28(2):507-523. PubMed ID: 28032992
[TBL] [Abstract][Full Text] [Related]
2. Design and Synthesis of Amphiphilic and Luminescent Tris-Cyclometalated Iridium(III) Complexes Containing Cationic Peptides as Inducers and Detectors of Cell Death via a Calcium-Dependent Pathway.
Hisamatsu Y; Shibuya A; Suzuki N; Suzuki T; Abe R; Aoki S
Bioconjug Chem; 2015 May; 26(5):857-79. PubMed ID: 25875312
[TBL] [Abstract][Full Text] [Related]
3. Cyclometalated Iridium(III) Complex-Cationic Peptide Hybrids Trigger Paraptosis in Cancer Cells via an Intracellular Ca
Balachandran C; Yokoi K; Naito K; Haribabu J; Tamura Y; Umezawa M; Tsuchiya K; Yoshihara T; Tobita S; Aoki S
Molecules; 2021 Nov; 26(22):. PubMed ID: 34834120
[TBL] [Abstract][Full Text] [Related]
4. Photochemical Properties of Red-Emitting Tris(cyclometalated) Iridium(III) Complexes Having Basic and Nitro Groups and Application to pH Sensing and Photoinduced Cell Death.
Kando A; Hisamatsu Y; Ohwada H; Itoh T; Moromizato S; Kohno M; Aoki S
Inorg Chem; 2015 Jun; 54(11):5342-57. PubMed ID: 25978770
[TBL] [Abstract][Full Text] [Related]
5. [Design and Synthesis of Functional Molecules Based on Complexation and Their Biological Applications].
Hisamatsu Y
Yakugaku Zasshi; 2016; 136(12):1601-1611. PubMed ID: 27904094
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and photochemical properties of pH responsive tris-cyclometalated iridium(III) complexes that contain a pyridine ring on the 2-phenylpyridine ligand.
Nakagawa A; Hisamatsu Y; Moromizato S; Kohno M; Aoki S
Inorg Chem; 2014 Jan; 53(1):409-22. PubMed ID: 24341415
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and anticancer activity of iridium(III) complex-peptide hybrids that contain hydrophobic acyl groups at the N-terminus of the peptide units.
Naito K; Yokoi K; Balachandran C; Hisamatsu Y; Aoki S
J Inorg Biochem; 2019 Oct; 199():110785. PubMed ID: 31419676
[TBL] [Abstract][Full Text] [Related]
8. Ester-Modified Cyclometalated Iridium(III) Complexes as Mitochondria-Targeting Anticancer Agents.
Wang FX; Chen MH; Hu XY; Ye RR; Tan CP; Ji LN; Mao ZW
Sci Rep; 2016 Dec; 6():38954. PubMed ID: 27958338
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and mitochondria-localized iridium (III) complexes induce cell death through pyroptosis and ferroptosis pathways.
Hu H; Zhang F; Sheng Z; Tian S; Li G; Tang S; Niu Y; Yang J; Liu Y
Eur J Med Chem; 2024 Mar; 268():116295. PubMed ID: 38437750
[TBL] [Abstract][Full Text] [Related]
10. Photoinduced anticancer activity studies of iridium(III) complexes targeting mitochondria and tubules.
Zhang WY; Yi QY; Wang YJ; Du F; He M; Tang B; Wan D; Liu YJ; Huang HL
Eur J Med Chem; 2018 May; 151():568-584. PubMed ID: 29656200
[TBL] [Abstract][Full Text] [Related]
11. Highly Charged, Cytotoxic, Cyclometalated Iridium(III) Complexes as Cancer Stem Cell Mitochondriotropics.
Laws K; Eskandari A; Lu C; Suntharalingam K
Chemistry; 2018 Oct; 24(57):15205-15210. PubMed ID: 30052298
[TBL] [Abstract][Full Text] [Related]
12. Mitochondria-targeting cyclometalated iridium(III)-PEG complexes with tunable photodynamic activity.
Li SP; Lau CT; Louie MW; Lam YW; Cheng SH; Lo KK
Biomaterials; 2013 Oct; 34(30):7519-32. PubMed ID: 23849346
[TBL] [Abstract][Full Text] [Related]
13. Luminescent cyclometalated iridium(III) polypyridine di-2-picolylamine complexes: synthesis, photophysics, electrochemistry, cation binding, cellular internalization, and cytotoxic activity.
Lee PK; Law WH; Liu HW; Lo KK
Inorg Chem; 2011 Sep; 50(17):8570-9. PubMed ID: 21834537
[TBL] [Abstract][Full Text] [Related]
14. On the antitumor properties of novel cyclometalated benzimidazole Ru(II), Ir(III) and Rh(III) complexes.
Yellol GS; Donaire A; Yellol JG; Vasylyeva V; Janiak C; Ruiz J
Chem Commun (Camb); 2013 Dec; 49(98):11533-5. PubMed ID: 24177492
[TBL] [Abstract][Full Text] [Related]
15. Mitochondria-targeted neutral and cationic iridium(III) anticancer complexes chelating simple hybrid sp
Li P; Guo L; Li J; Yang Z; Fu H; Lai K; Dong H; Fan C; Liu Z
Dalton Trans; 2024 Jan; 53(5):1977-1988. PubMed ID: 38205595
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and in vitro antitumor activity of novel iridium(III) complexes with enantiopure C2-symmetrical vicinal diamine ligands.
Yang Q; Chang J; Song J; Qian MT; Yu JM; Sun X
Bioorg Med Chem Lett; 2013 Aug; 23(16):4602-7. PubMed ID: 23849808
[TBL] [Abstract][Full Text] [Related]
17. Cyclometalated iridium(iii) complexes induce mitochondria-derived paraptotic cell death and inhibit tumor growth in vivo.
He L; Wang KN; Zheng Y; Cao JJ; Zhang MF; Tan CP; Ji LN; Mao ZW
Dalton Trans; 2018 May; 47(20):6942-6953. PubMed ID: 29721561
[TBL] [Abstract][Full Text] [Related]
18. Luminescent cyclometalated iridium(III) polypyridine indole complexes--synthesis, photophysics, electrochemistry, protein-binding properties, cytotoxicity, and cellular uptake.
Lau JS; Lee PK; Tsang KH; Ng CH; Lam YW; Cheng SH; Lo KK
Inorg Chem; 2009 Jan; 48(2):708-18. PubMed ID: 19099443
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of anticancer effect in vitro and in vivo of iridium(III) complexes on gastric carcinoma SGC-7901 cells.
Zhang WY; Wang YJ; Du F; He M; Gu YY; Bai L; Yang LL; Liu YJ
Eur J Med Chem; 2019 Sep; 178():401-416. PubMed ID: 31202128
[TBL] [Abstract][Full Text] [Related]
20. Design of luminescent biotinylation reagents derived from cyclometalated iridium(III) and rhodium(III) bis(pyridylbenzaldehyde) complexes.
Leung SK; Kwok KY; Zhang KY; Lo KK
Inorg Chem; 2010 Jun; 49(11):4984-95. PubMed ID: 20465281
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
